PUBLISHER: The Business Research Company | PRODUCT CODE: 1939346
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939346
Biologic hernia repair mesh is an implant made from processed human or animal tissues, used to strengthen and support weakened areas during hernia repair surgeries. The mesh is gradually absorbed by the body, encouraging natural tissue regeneration, which makes it particularly suitable for patients at higher risk of infection or those undergoing complex repairs.
The primary types of biologic hernia repair mesh include partially absorbable and fully absorbable meshes. Partially absorbable meshes are composed of both absorbable and non-absorbable materials. Common variants include porcine, bovine, and human dermis meshes, among others. These meshes are distributed through various channels such as direct sales, distributors, online platforms, and pharmacies. They are used in procedures like inguinal, ventral, and umbilical hernia repairs. Key end users include hospitals, ambulatory surgical centers, clinics, and other healthcare facilities.
Tariffs are impacting the biologic hernia repair mesh market by increasing costs associated with importing processed biologic tissues and advanced manufacturing equipment. Product types such as porcine and bovine-derived meshes are particularly impacted, with North America and Asia-Pacific regions experiencing pricing pressures due to cross-border trade dependencies. These cost increases can slow adoption in price-sensitive healthcare systems. However, tariffs have also encouraged regional sourcing, local tissue processing, and investments in domestic manufacturing capabilities, supporting long-term supply chain stability.
The biologic hernia repair mesh market research report is one of a series of new reports from The Business Research Company that provides biologic hernia repair mesh market statistics, including biologic hernia repair mesh industry global market size, regional shares, competitors with a biologic hernia repair mesh market share, detailed biologic hernia repair mesh market segments, market trends and opportunities, and any further data you may need to thrive in the biologic hernia repair mesh industry. This biologic hernia repair mesh market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biologic hernia repair mesh market size has grown strongly in recent years. It will grow from $1.85 billion in 2025 to $1.99 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing incidence of hernia disorders, limitations of synthetic mesh in infected cases, growing surgical procedure volumes, rising hospital-based hernia repairs, early adoption of tissue-based implants.
The biologic hernia repair mesh market size is expected to see strong growth in the next few years. It will grow to $2.63 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to advancements in biologic tissue processing technologies, growing demand for patient-specific repair solutions, rising awareness of post-surgical complications, expansion of ambulatory surgical centers, increasing surgeon preference for regenerative materials. Major trends in the forecast period include rising preference for biologic mesh in high-risk hernia repairs, increasing adoption of absorbable and regenerative mesh solutions, growing use in complex and contaminated surgical cases, expansion of minimally invasive and laparoscopic hernia procedures, higher clinical focus on reduced infection and recurrence rates.
The rising number of hernia cases is anticipated to drive the expansion of the biologic hernia repair mesh market in the coming years. Hernia cases denote instances where an internal organ or tissue abnormally protrudes through a weakened area in the muscle or connective tissue. The increase in hernia cases is linked to growing obesity rates, as excess body weight places additional pressure on abdominal muscles, thereby heightening the risk of hernia development. Biologic hernia repair mesh helps in managing hernia cases by providing a scaffold made of natural tissue that supports healing, integrates with the patient's body, and reduces the chances of rejection or chronic inflammation. For example, in November 2024, the British Hernia Society, a UK-based professional organization representing hernia surgeons in the United Kingdom and Ireland, reported that its newly launched British Hernia Society Registry had registrations from over 100 surgeons at its inaugural conference. By January 2025, the registry had recorded 400 cases contributed by 30 surgeons across 31 hospitals, demonstrating rapid early adoption and underscoring the ongoing clinical burden of hernia cases. Consequently, the rising prevalence of hernia cases is fueling the growth of the biologic hernia repair mesh market.
Leading companies in the biologic hernia repair mesh market are focusing on the development of innovative solutions, such as reinforced biologic mesh, to improve strength, flexibility, and tissue integration. Reinforced biologic mesh combines biologic tissue with synthetic fibers to enhance durability, support tissue regeneration, and minimize the risk of hernia recurrence. For example, in April 2024, TELA Bio Inc. introduced OviTex inguinal hernia repair (IHR), a reinforced biologic mesh designed for inguinal hernia repair. This mesh is specifically intended for laparoscopic and robotic procedures and uses a combination of biologic ovine extracellular matrix (ECM) and minimal synthetic polymer to deliver strength, support rapid tissue integration, and reduce the risk of complications. It offers advantages such as lower recurrence rates, faster healing, and higher patient satisfaction, addressing the limitations of traditional synthetic meshes.
In February 2024, RTI Surgical Inc., a US-based contract development and manufacturing organization (CDMO), acquired Cook Biotech Inc. for an undisclosed sum. This acquisition allows RTI Surgical to position itself as the only regenerative medicine CDMO capable of providing both allograft and xenograft biomaterials at scale, strengthening its leadership in soft tissue and expanding its market footprint. Cook Biotech Inc. is a US-based company specializing in regenerative medicine, manufactures biologic hernia repair mesh.
Major companies operating in the biologic hernia repair mesh market are Johnson And Johnson, Medtronic plc, DSM Biomedical, W L Gore And Associates Inc, Meril Life Sciences, Cook Medical LLC, Integra LifeSciences Corporation, MTF Biologics, LifeCell Corporation, AlloSource, TELA Bio Inc, Kerecis, Assut Europe S p A, Serag Wiessner GmbH And Co KG, Aroa Biosurgery Limited, ACell Inc, Tissue Regenix Group plc, RTI Surgical Inc, Beijing Datsing Bio Tech Co Ltd, Shanghai Pine And Power Biotech Co Ltd, Axogen Inc, XenoSure Biologics
North America was the largest region in the biologic hernia repair mesh market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologic hernia repair mesh market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the biologic hernia repair mesh market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The biologic hernia repair mesh market consists of sales of Strattice reconstructive tissue matrix, Surgimend, and Ovitex. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biologic Hernia Repair Mesh Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses biologic hernia repair mesh market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for biologic hernia repair mesh ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biologic hernia repair mesh market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.